Myeloid dendritic cells and HIV latency in resting T-cells Nitasha A Kumar, Vanessa A Evans, Suha Saleh, Candida de Fonseca Pereira, Paula Ellenberg, Paul.

Slides:



Advertisements
Similar presentations
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Advertisements

Measuring the latent HIV Reservoir
Opportunistic Bacterial Infections in Inflammatory Bowel Disease By: Christina Philips.
2014 “Towards an HIV Cure” symposium Melbourne Following in vitro culture with myeloid dendritic cells, negative regulators of T cell activation are expressed.
Unique integration patterns in an in vitro model of HIV-1 latency. Suha M. Saleh, Dimitrios Vatakis, Andrew Harman, Anthony Cunningham, Paul U. Cameron,
Contribution of the immune system to HIV persistence Sharon R Lewin Director, Infectious Disease Unit, Alfred Hospital Professor, Department of Medicine,
Gag-positive reservoir cells can be identified by a new technique and can be cleared by CTL ? Una O’Doherty June 29, 2013.
Controversies in HIV Cure Research Debate 1. Is there ongoing replication under HAART? Mario Stevenson and Frank Maldarelli Moderator: Steve Deeks.
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup, MD.
Alternative RNA splicing in latently infected T cells generates chimeric cellular:HIV mRNAs with the potential to generate Tat and reactivate infection.
Strategies for Targeting and Eradicating the HIV Reservoir
Hematopoietic stem cell based gene therapy for HIV diseases
2014 “Towards an HIV Cure” symposium Melbourne The Immune Checkpoints PD-1, LAG-3 and TIGIT are Biomarkers of HIV Infected Cells During ART and Identify.
Introduction to Autoimmunity Alon Monsonego, Ph.D. The department of Microbiology and Immunology Tel:
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
The role of PI3K signaling pathways in HIV-1 infection of resting CD4+T-cells Suha Saleh, Paul Cameron, Georgina Sallmann, Anthony Jaworowski, and Sharon.
Future directions in HIV basic science research The hunt for a cure.
Latent infection and cellular reservoirs
2014 “Towards an HIV Cure” symposium Melbourne
Myeloid cells matter Conclusions. Glut1+ CD14++ CD16+ Associated with inflammatory markers HIV Immune activation HIV-related diseases Joshua Anzigen:
Novel Approaches: Treatment and HIV Pathogenesis L. Trautmann, Ph.D. VGTI Florida.
Dendritic Cells – Target of HNSCC Immune Escape can be supported with PAMP´s Barbara Wollenberg Universitätsklinikum Schleswig-Holstein, Campus Lübeck.
Non-Infectious Papilloma virus–like Particles (VLPs) inhibit HIV-1 replication: Implications for immune control of HIV-1 replication by IL-27. Laboratory.
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms.
Introduction: Red blood cells can theoretically be used as a platform for therapeutic proteins because they are both long lived and naturally occur in.
Are we most likely to cure HIV with gene therapy? Sharon R Lewin Director, Infectious Disease Unit, Alfred Hospital Professor, Department of Medicine,
Myeloid dendritic cells induce HIV-1 latency in non- proliferating CD4 + T cells IAS WORKSHOP, 16 & 17 JULY 2010.
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
Infectious diseases Tissue transplantation Elimination of tumors Autoimmune diseases Gatekeeper function Sensing pathogens Priming adaptive immune responses.
Peripheral T follicular Helper Cells (pTfh)
Liposomal Transfection of Dendritic Cells with gag mRNA Stimulates HIV-1 Specific Immune Responses Winni De Haes 1, Charlotte Pollard 1,4,Céline Merlin.
The Current State of Knowledge on Innate and Adaptive Responses
Study Design UIHC HIV Clinic Patients Invitation – Informed Consent Heparinized Blood/Serum Obtained CD4, HIV VL measured Serum => GBV-C VL Cells => flow.
HIV: Science, Sex and Society. Lecture 1. Mechanisms of viral persistence in the face of antiviral therapy. Mario Stevenson, Ph.D Department of Medicine.
BIT225 Reduces the Intracellular HIV-1 Burden Within Monocyte Derived Dendritic Cells, Resulting in Reduced Transfer of Virus to more Permissive CD4 +
PROFESSIONAL ANTIGEN PRESENTING CELLS
Cigarette Smoke Extract Suppresses Human Dendritic Cell Function Leading to Preferential Induction of Th-2 Priming 高丰光 Robert Vassallo The Journal of Immunology,
ANTIGEN PRESENTING CELLS. Professional antigen presenting cells Definition: Antigen-presenting cells (APCs) are a heterogeneous group of immune cells.
The Future of HIV/AIDS: The Road to a Cure. How HIV persists during therapy?  Ongoing viral replication occurs in subjects on suppressive HAART (TW Chun,
Dendritic Cell Subsets June 3, 2005 MIMG 261 Stephan Krutzik, Ph.D.
Routine vaccination and maintenance of serological memory in HIV infected children Moderators: Berhanu Gudeta, Ethiopia Francesca Chiodi, Sweden Cell Damage.
Background  HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression 
#AIDS2016 HIV Persists in Colon and Blood CCR6+ T-Cells During Viral Suppressive ART Jean-Pierre Routy on behalf of : A. Gosselin, T.
HIV-infected patients, and have proliferative defects
CATEGORY: CELLS DENDRITIC CELLS Dendritic Cells
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
Volume 94, Issue 2, Pages (March 2014)
Figure 1. CD11b+CD33+CD14+HLA-DR−/lo myeloid-derived suppressor cell expansion by human immunodeficiency virus.
PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching.
HIV Cure: Current Status and Future Perspectives
PANEL 1 All events Lymphocytes (FSC-A v SSC-A)
Anifrolumab inhibits cytokine production, plasmacytoid dendritic cell (pDC) activation and the type I (interferon gene signature) IFN gene signature. Anifrolumab.
Dendritic Cell Immunotherapy for the Treatment of Neoplastic Disease
Didier Trono, Flavia Marzetta  Cell Host & Microbe 
by Rui Zhang, Jeffrey D. Lifson, and Claire Chougnet
HIV-1 Latency by Transition
The block-and-lock approach
Differentiation and Functions of CD8+ Effector T Cells
Volume 135, Issue 6, Pages (December 2008)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Nat. Rev. Nephrol. doi: /nrneph
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3  Chiara Camisaschi, Annamaria De Filippo, Valeria.
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
Fig. 1 pDCs infiltrate the skin of SSc patients and spontaneously secrete IFN-α and CXCL4. pDCs infiltrate the skin of SSc patients and spontaneously secrete.
Volume 137, Issue 5, Pages (November 2009)
Skin-Derived Dendritic Cells Induce Potent CD8+ T Cell Immunity in Recombinant Lentivector-Mediated Genetic Immunization  Yukai He, Jiying Zhang, Cara.
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus  Madhvi Menon, Paul A. Blair,
Introduction. Activation of HIV-Specific CD8+ T Cells from HIV+ Donors by Vesatolimod.
Volume 38, Issue 2, Pages (February 2013)
PD-1 inhibition stimulates the proliferation and cytokine secretion of exhausted/senescent CD8+ T cells in vitro. PD-1 inhibition stimulates the proliferation.
Presentation transcript:

Myeloid dendritic cells and HIV latency in resting T-cells Nitasha A Kumar, Vanessa A Evans, Suha Saleh, Candida de Fonseca Pereira, Paula Ellenberg, Paul U Cameron, Sharon R Lewin. International AIDS Conference, Washington DC, July 2012

Ex vivo tissue blocks Eckstein et al, Immunity 2001; 15: 671; Kreisberg et al., J Exp Med 2006; 203:865; Infection of resting CD4 + T-cells Unactivated resting cells Resting CD4+ T-cell Swiggard et al., J Virol 2005; 79(22): ; Lassen et al., Plos One 2012; 7(1):e30176 chemokines In vitro Saleh et al., Blood 2007;110:416; Cameron et al., Proc Natl Acad Sci 2010;107(39): CCR7 (CCL19/21) CXCR3 (CXCL9/10) CCR6 (CCL20)

Ex vivo tissue blocks Eckstein et al, Immunity 2001; 15: 671; Kreisberg et al., J Exp Med 2006; 203:865; Infection of resting CD4 + T-cells Unactivated resting cells Resting CD4+ T-cell Swiggard et al., J Virol 2005; 79(22): ; Lassen et al., Plos One 2012; 7(1):e30176 Saleh et al., Blood 2007;110:416; Cameron et al., Proc Natl Acad Sci 2010;107(39): In vitro Dendritic cells

Resting CD4 + T-cells SNARF or Efluor DC added 1:10 AND PBMC + Mouse-anti- human CD3, CD11b, CD19 CD11c CD123 Myeloid DC Plasmacytoid DC HLA-DR Lineage cocktail Bulk DC

PHA 5 Days Amplification in PBMC PBMC Non-proliferating SNARF hi Not productively infected EGFP - EGFP SNARF 5 days SNARF hi EGFP - CD4 + T-cells Resting CD4 + T cells SNARF or Efluor DC added 1:10 AND Productive infection SNARF EGFP Latent infection R5-EGFP-HIV-1 (2h pulse) 1 day

DC induce latent infection in non- proliferating (SNARF hi ) cells

SNARF hi EGFP - T-cells express CD69

mDC specifically mediate HIV latency Days 05 +pDC Productive +mDC + + Alu-LTR PCR 5 days Latent PHA SNARF hi EGFP - CD4 + T-cells PBMC

SNARF hi EGFP - T-cells express PD1 Chomont et al., Nature Med 2010

Establishment of latency not related to degree of productive infection MDDC = monocyte derived DCs

Myeloid DC induce latency in memory not naïve CD4 + T-cells

Cytokines/chemokines in mDC-T- cell co-cultures Days 05 +pDC +mDC + + Bead arrays

Neutralization of DC-derived chemokines does not inhibit latency

Neutralisation of select cytokines does not inhibit latency

24 hrs EGFP HIV-1 DC DC-T cell proximity required for DC- induced latency CD4 + T DC CD4 + T DC

DC-T-cell culture supernatant doesn’t facilitate latency CD4 + T DC CD4 + T n=3 CD4 + T Supernatant

Conclusions  Myeloid DC facilitate establishment of HIV latency in resting memory CD4 + T-cells via direct infection.  Close proximity (± cell contact) of mDC and T- cells required  Role for negative regulators in the establishment/maintenance of DC-induced latency

Implications  Efficient infection of resting T-cells in close contact with mDC and HIV may explain the rapid early establishment of the latent reservoir.  If infectious virus persists in tissues such as LN in patients on cART, mDC may facilitate ongoing infection of resting T-cells leading to replenishment of the reservoir.

Acknowledgements  Department of Infectious Diseases, Monash University –Sharon Lewin –Paul Cameron –Vanessa Evans –Suha Saleh –Paula Ellenberg –Candida de Fonseca Pereira –Ajantha Solomon  University of Melbourne –Damian Purcell  Flow Cytometry Facility, Monash University –Geza Paukovics –Michael Thomson –Jeanne Le Masurier  Vaccine Gene Therapy Institute –Rafick Sekaly –Nicholas Chomont